U.S. markets closed

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
5.26-0.18 (-3.31%)
Al cierre: 04:00PM EDT
5.17 -0.09 (-1.71%)
Fuera de horario: 04:24PM EDT

ProPhase Labs, Inc.

711 Stewart Avenue
Suite 200
Garden City, NY 11530
United States
215 345 0919
https://www.prophaselabs.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo113

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Ted William KarkusChairman & CEO902.2kN/D1959
Mr. Jed A. LatkinChief Operating Officer & Head of Finance DepartmentN/DN/D1974
Mr. Robert A. Morse Jr.Controller, Principal Financial Officer & Principal Accounting OfficerN/DN/D1975
Mr. Sergio MirallesExecutive VP & Chief Information OfficerN/DN/DN/D
Mr. Jason KarkusPresident of Nebula GenomicsN/DN/DN/D
Mr. Kamal ObbadSenior VP and Director of Sales & Marketing - Nebula GenomicsN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It also offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de ProPhase Labs, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.